INTERNATIONAL PATENT: HANGZHOU GLUELINKER BIO THERAPEUTICS CO., LTD, 杭州胶联生物医药科技有限公司 FILES APPLICATION FOR "NOVEL SUBSTITUTED HETEROCYCLIC COMPOUND SERVING AS VAV1 PROTEIN TARGET DEGRADATION AGENT"

GENEVA, Feb. 8 -- HANGZHOU GLUELINKER BIO THERAPEUTICS CO., LTD (Room 1914, Bldg 2, 2 Kejiyuan Road, Baiyang Street, Qiantang DistrictHangzhou, Zhejiang 310018), 杭州胶联生物医药科技有限公司 (中国浙江省杭州市钱塘区白杨街道科技园路2号2幢1914室) filed a patent application (PCT/CN2025/111202) for "NOVEL SUBSTITUTED HETEROCYCLIC COMPOUND SERVING AS VAV1 PROTEIN TARGET DEGRADATION AGENT" on Jul 29, 2025. With publication no. WO/2026/026773, the details related to the patent application was published on Feb 05, 2026.

Notably, the pat...